. Randomised controlled trial of effects of early discharge after surgery for breast cancer.
INTRODUCTION:
Post-mastectomy breast reconstruction (PMBR) is important for many women undergoing treatment for breast cancer; studies show that PMBR can improve body image, sexuality and overall quality of life.
1 Aesthetic outcome is a significant component of patient satisfaction after PMBR and historically, has primarily been evaluated by patient and surgeon. 2 The aim of this study is to evaluate public opinion of autologous and implant-based breast reconstruction.
METHODS:
In February 2017, a survey was distributed via a Crowdsourcing platform to members of the general population. Respondents rated the results of fourteen women's breast reconstructions following treatment (seven autologous and seven implant-based PMBRs), ranking the attractiveness using a Likert scale with regard to shape, symmetry, nipples, natural appearance and overall appearance. Higher scores indicted a more positive response.
RESULTS:
A total of 203 responses were retrieved in the study period. The majority of respondents were Caucasian 61.6%) males (64.5%), with a mean age of 34.4 years. When comparing autologous with implant PMBR, mean overall appearance score was higher in autologous (3.07 vs. 2.83, p<0.001), as was that of the mean shape score (3.24 vs. 3.10, p=0.002), nipple score (3.06 vs. 2.87, p<0.001), scarring score (3.44 vs. 2.95, p<0.001), natural appearance score (3.29 vs. 2.79, p<0.001). On multivariate analysis, autologous PMBR was predictive of a higher preference score compared with implant PMBR (OR 1.42, CI 1.24-1.64).
CONCLUSION:
The public demonstrated an overall preference for the aesthetics of autologous over implant-based post-mastectomy breast reconstruction, independent of respondent characteristics. This information may provide further evidence supporting the use of autologous postmastectomy breast reconstruction. 
METHODS:
This study was a prospective, randomized, placebo controlled double blind clinical trial with ethical approval. Thirty-two consecutive women undergoing subpectoral breast augmentation were enrolled. Patient received general anesthesia and were allocated randomly to two study groups. Patient in group 1 received intercostal nerve block using 10 ml of 0.25% bupivacaine with epinephrine in one side of the breast and normal saline in another side prior to implant placement. Patient in group2 received locally administered of 20 ml of 0.25% bupivacaine with epinephrine at the surgical site in one side of breast and placebo infiltration of normal saline in the contralateral breast. Both the patient and evaluator were blinded to the side given anesthesia and method of anesthesia used. Primary outcome was pain measured with the visual analogue scale recorded at 2, 6, 12, 24 and 48 hours at rest and after movement. Pain score was compared between breasts (anesthesia vs placebo) and between types of anesthesia. By comparing analgesic outcomes in the same patients, we could control for the subjectivity of pain assessments. A p-value of < 0.05 was considered statistically significant.
RESULTS:
Postoperative pain gradually decreased with time in all patients. No difference in pain scores was found over time at rest or on movement when comparing Intercostal nerve block to placebo or local infiltration to placebo. There was also no statistically significant difference in pain between intercostal nerve block and local infiltration of bupivacaine. All patients can return to normal activities within 48 hours after surgery.
CONCLUSION:
Our study did not demonstrate any statistically significant difference in postoperative pain when comparing those receiving intercostal nerve block versus placebo and those receiving local administered bupivacaine versus placebo. No beneficial effect of reducing postoperative pain demonstrated regardless of the type of local anesthetic used.
